1999

Feb 25, 1999
Guidant Announces First Implant of CONTAK CD / EASYTRAK System for Treatment of Congestive Heart Failure

Indianapolis, IN - Guidant Corporation (NYSE and PSX: GDT), a worldwide leader in cardiac rhythm management systems, today announced the start of a clinical study to evaluate the use of a new...

Feb 19, 1999
Guidant Announces FDA Approval for a New Indication for its Coronary Stents, Including a 2.5mm Diameter and a 38mm Length

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) a world leader in the treatment of coronary artery disease, today announced FDA approval to market the ACS MULTI-LINK DUET(tm) Coronary...

Feb 2, 1999
Guidant Corporation Completes Purchase of Sulzer Medica's Electrophysiology Business, Announces Related Product and Manufacturing Strategy

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiovascular therapy, announced late yesterday that it had completed its acquisition of Sulzer Medica''s...

Jan 28, 1999
Guidant 1998 Sales Grow 43 Percent to Record $1.9 Billion; Fourth Quarter Earnings of $0.29 per Share Increase 12 Percent over 1997

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced fourth quarter sales of $493.5 million, bringing total sales for the company to a record $1.897 billion for 1998....

Jan 27, 1999
Guidant Announces First Implant of VENTAK VR Defibrillation System

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable defibrillation systems, today announced the first implant of the VENTAK® VR AICD(tm) Automatic...

Show 5102550100 per page
Top